11º Simpósio Médico Anual da ECD, Birmingham, AL

Dr. Gaurav Goyal
Universidade do Alabama em Birmingham
Birmingham, Alabama US
1º de maio de 2026

Birmingham Medical Symposium Group Picture 2026

Resumo do Simpósio

Approximately 44 medical professionals from 6 countries attended the Annual ECD Medical Symposium in 2026. 15 oral abstracts were presented, along with an additional 9 poster presentations. The keynote speaker, Nicole Coufal, MD, PhD, delivered a talk titled “Diversity and Degeneration in Neurohistiocytic Disease.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.

Programas com a agenda do simpósio

Ordem do dia

ApresentadorSlides da apresentaçãoVídeo em inglês
Dr. Gaurav GoyalVer slideSejam bem-vindos a Birmingham e à 11ª Conferência Internacional Anual sobre a Doença de Erdheim-Chester
Nicole Coufal, MD (Keynote Speaker)Ver slideDiversidade e degeneração na doença neurohistiocítica
Dr. Benjamin DurhamVer slideMutações no gene ARAF causam neoplasias histiocíticas in vivo e fornecem informações sobre a origem celular
Florian Houdu, MDVer slideTracking BRAF V600E Persistence under MEK Inhibition in Histiocytoses: a B-cell–enriched signal
Irena Ungureanu, MDVer slideDistribution of MAP2K1 Variants Across Peripheral Blood Cells in Erdheim-Chester Disease and Other Histiocytoses
Dr. Matthew CollinVer slideThe Clonal Origin and Evolution of High-Risk Multisystem Histiocytosis in Adults
Dongni Yi, MDVer slideMutações no gene KRAS em neoplasias histiocíticas: espectro de mutações e resposta à inibição da MEK
Dongni Yi, MDVer slideA superexpressão da ciclina D1 induz estresse de replicação e gera vulnerabilidades terapêuticas em neoplasias histiocíticas
Jérôme Razanamahery, MDVer slideClonal Hematopoiesis Predicts Response to Interferon-α in Erdheim-Chester Disease and Myeloproliferative Neoplasms
Félicien Triboulet, MDVer slideImpact of Additional Genetic Variants in the Course of Erdheim-Chester Disease… a Multicentric Longitudinal Study of 445 French Patients
Guneet Janda, MDVer slidePatterns of Presentation and Outcomes in Adults Xanthogranulomas
Mustafa Abomohsen, MDVer slideIndisponível
Carla Isabel Borre, MDVer slideReal World Frontline Systemic Anti-Cancer Treatment Patterns and Outcomes in Erdheim–Chester Disease
Dr. Gaurav GoyalVer slideBurden of Chronic Health Conditions After Diagnosis of Erdheim–Chester Disease (ECD): Early Results from the Histiocytic Disorder Survivor Study
Julien Haroche, Médico, DoutorVer slideDestombes-Rosai-Dorfman Disease: Clinical, Molecular Characteristics and Treatment Response: data from a retrospective cohort of 107 patients
Anneka Johnston, MDVer slideConsiderations for Assessment and Treatment of Neuropsychiatric Symptoms in ECD
Matthew Collin, médico, PhDVer slideAll that glitters: retro-orbital xanthogranuloma or ECD?
Dra. Jithma AbeykoonVer slideA pista estava na pressão arterial: doença de Erdheim–Chester atípica
Jerome HensonAliança Global da ECD rumo ao futuroAliança Global da ECD rumo ao futuro

Fotografias

Jantar Comemorativo

Simpósio Médico

Recepção Médica

Reunião do Centro de Atendimento